Icahn School of Medicine at Mount Sinai: clinical-trial pipeline
Icahn School of Medicine at Mount Sinai is the sponsor of 772 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 200 are not yet finished and 4 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 522 |
| Phase 2 | 86 |
| Phase 4 | 73 |
| Phase 1 | 31 |
| Phase 3 | 25 |
| Phase 1/2 | 22 |
| Early phase 1 | 8 |
| Phase 2/3 | 4 |
| Not stated | 1 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 452 |
| Recruiting | 149 |
| Terminated | 83 |
| Active, not recruiting | 29 |
| Not yet recruiting | 22 |
| Withdrawn or not authorised | 21 |
| Unknown | 12 |
| Suspended or halted | 4 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 110 |
| Cardiovascular | 103 |
| Psychiatry and mental health | 91 |
| Neurology | 64 |
| Infectious disease and vaccines | 63 |
| Gastroenterology and liver | 62 |
| Metabolic and endocrine (diabetes, obesity) | 59 |
| Nephrology and urology | 49 |
| Rare and genetic diseases | 48 |
| Immunology and rheumatology | 45 |
| Women's health and obstetrics | 40 |
| Dermatology | 37 |
Countries
| Country | Trials |
|---|---|
| United States | 754 |
| Canada | 13 |
| United Kingdom | 6 |
| Italy | 6 |
| Germany | 4 |
| France | 4 |
| Spain | 3 |
| Brazil | 2 |
| Mexico | 2 |
| Netherlands | 2 |
| Argentina | 1 |
| Chile | 1 |
| Colombia | 1 |
| Denmark | 1 |
| Ghana | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-21 | New trial posted | Parkinson's Disease in Type 1 Gaucher Disease |
| 2026-09-21 | New trial posted | The Use of Remimazolam for TEE |
| 2026-09-09 | New trial posted | Personalized Exercise Recommendations for Chronic Pelvic Pain Using Reinforcement Learning |
| 2026-09-01 | New trial posted | Grape Impact on Human Gut Microbiome |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT04045665 | Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG | Phase 3 | Recruiting | Brazil, Canada, Germany, United Kingdom +1 |
| NCT06930703 | Cannabidiol in Sickle Cell Disease | Phase 1/2 | Recruiting | United States |
| NCT05539729 | Vancomycin Study in Multiple Sclerosis (MS) | Phase 1 | Recruiting | United States |
| NCT07508488 | Deucravacitinib in the Treatment of Cicatricial Alopecias | Phase 2 | Recruiting | United States |
| NCT06771167 | Building Community Resilience Program | Not applicable | Recruiting | United States |
| NCT04305717 | Use of ReDS Technology in Patients With Acute Heart Failure | Not applicable | Recruiting | United States |
| NCT06734767 | The Effect of an MBSR Course on Medical Trainee and Medical Academic Faculty Stress and Burnout | Not applicable | Recruiting | United States |
| NCT07539623 | Suzetrigine-enhanced MultimOdal Opioid-sparing THerapy in Cardiac and Bariatric SURGery | Phase 3 | Recruiting | United States |
| NCT06228209 | Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer | Not applicable | Recruiting | United States |
| NCT05562258 | Development and Testing of a Peer-Coaching Model for the Treatment of Eating Disorders | Not applicable | Recruiting | United States |
| NCT06653400 | Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy | Phase 1 | Recruiting | United States |
| NCT06069843 | Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment | Phase 2 | Active, not recruiting | United States |
| NCT07730853 | Isocaloric Navy-Bean Substitution in Adults With MASLD | Not applicable | Not yet recruiting | United States |
| NCT07219563 | Alnuctamab for Refractory SLE (LATTE Study) | Phase 1 | Recruiting | United States |
| NCT05835466 | Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120) | Phase 2 | Recruiting | United States |
| NCT05982925 | Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders | Not applicable | Recruiting | United States |
| NCT07091877 | Cocaine Cue-reactivity Incubation Study | Not applicable | Recruiting | United States |
| NCT05968560 | Telehealth Cognitive Behavioral Therapy for Youth at Risk for Psychosis | Not applicable | Recruiting | United States |
| NCT05978167 | Targeting Drug Memories With Methylphenidate | Early phase 1 | Active, not recruiting | United States |
| NCT03850600 | Modulating Early Life Microbiome Through Dietary Intervention in Crohn's Disease | Not applicable | Active, not recruiting | United States |
| NCT06858787 | Validating CGM for GDM | Not applicable | Recruiting | United States |
| NCT06858774 | Use of Circadian Reset Technology to Alter REM Sleep and Appetitive Control in Patients With Binge Eating Dis… | Not applicable | Recruiting | United States |
| NCT07310875 | Gastric Ultrasound in Patients Who Have Undergone Bariatric Surgery | Not applicable | Not yet recruiting | United States |
| NCT07039019 | Study of the Feasibility and Efficacy of PrednisonE for Non-specifiC pleuriTis | Early phase 1 | Recruiting | United States |
| NCT04199000 | Clinical and Basic Investigations Into Congenital Disorders of Glycosylation | Not applicable | Recruiting | United States |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Icahn School of Medicine at Mount Sinai clinical trials: 200 open, 29 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/icahn-school-of-medicine-at-mount-sinai/, data as of 2026-10-25.